|
April 23, 2009: 06:37 AM EST
UK ingredients giant Tate & Lyle has gained an exclusive right to market A. Holliday’s high-concentrate green tea extract in Europe, the Middle East and Africa. A. Holliday, a Canadian tea and coffee specialist, produces Teawell 95, a 95 percent concentrate of epigallocatechin gallate (EGCG), the most bioactive component of green tea. EGCG is reputed to increase metabolism, maintain blood glucose levels, and benefit the heart. Tate & Lyle, known for its sugars and starches, has been expanding into a range of healthier options through partnerships with other companies, such as Lipid Nutrition. It has produced a range of prototype products containing Teawell 95, incorporating its sweeteners, and expects the first product to be on the market next year. Coca-Cola is in the firing line in some States of the US over its claim that its EGCG-based beverage, Enviga, can burn calories.
"Tate & Lyle agree exclusive distribution rights for new green tea extract, TEAWELL 95, in Europe, Middle East and Africa ", Tate & Lyle, April 23, 2009, © Tate & Lyle
|
Domains
HEALTH & WELLNESS
Body
Mind
Stress Management
Better For You
Bones & Joints
Immunity
Geographies
Worldwide
North America
EMEA
United States of America
Canada
Europe
Middle East- Africa
United Kingdom
Categories
Companies, Organizations
Press Release
Products & Brands
Trends
|